WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H530789
CAS#: 120578-22-5
Description: 1-Dodecanoyl-sn-glycerophosphoethanolamine is a bioactive cehmical.
Hodoodo Cat#: H530789
Name: 1-Dodecanoyl-sn-glycerophosphoethanolamine
CAS#: 120578-22-5
Chemical Formula: C17H36NO7P
Exact Mass: 397.22
Molecular Weight: 397.449
Elemental Analysis: C, 51.37; H, 9.13; N, 3.52; O, 28.18; P, 7.79
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: 1-Dodecanoyl-sn-glycerophosphoethanolamine
IUPAC/Chemical Name: Dodecanoic acid, 3-(((2-aminoethoxy)hydroxyphosphinyl)oxy)-2-hydroxypropyl ester, (R)-
InChi Key: IZDRGPDUDLWAGR-MRXNPFEDSA-N
InChi Code: InChI=1S/C17H36NO7P/c1-2-3-4-5-6-7-8-9-10-11-17(20)23-14-16(19)15-25-26(21,22)24-13-12-18/h16,19H,2-15,18H2,1H3,(H,21,22)/t16-/m1/s1
SMILES Code: CCCCCCCCCCCC(OC[C@@H](O)COP(O)(OCCN)=O)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 397.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Wolf DE, Winiski AP, Ting AE, Bocian KM, Pagano RE. Determination of the transbilayer distribution of fluorescent lipid analogues by nonradiative fluorescence resonance energy transfer. Biochemistry. 1992 Mar 24;31(11):2865-73. PubMed PMID: 1550813.
2: Gow A, Auton W, Smith R. Interactions between bovine myelin basic protein and zwitterionic lysophospholipids. Biochemistry. 1990 Feb 6;29(5):1142-7. PubMed PMID: 1691016.
3: Wakamatsu K, Choung SY, Kobayashi T, Inoue K, Higashijima T, Miyazawa T. Complex formation of peptide antibiotic Ro09-0198 with lysophosphatidylethanolamine: 1H NMR analyses in dimethyl sulfoxide solution. Biochemistry. 1990 Jan 9;29(1):113-8. PubMed PMID: 2157477.